Meal photos, glucose context, and editable estimates in one reviewable record.
GlucIQ
Type 1 Diabetes

The Artificial Pancreas Is Here. What It Actually Does.

· 3 min read · Reviewed by GlucIQ Clinical Review Workflow
#closed-loop#automated-insulin-delivery#cluster:closed-loop

For decades, “artificial pancreas” was a phrase for science fiction. Now it’s a thing you can actually wear — and hundreds of thousands of people do.

It’s not a transplant. It’s not a cure. But it’s the closest thing to a working pancreas you can buy, and the trials are genuinely impressive.

What it actually is

A closed-loop system is three pieces working together:

  • A CGM that reads your glucose every few minutes.
  • A pump that delivers insulin.
  • A computer (usually the pump itself) that connects them — deciding, every few minutes, how much insulin to deliver.

That’s the loop: sense → decide → deliver → repeat. The system adjusts your background insulin automatically, second by second, based on where your glucose is and where it’s heading.

“Hybrid” means you still push the button for meals. The system handles the background; you handle the boluses.

What the trials found

The numbers are real:

  • In a 6-month trial, closed-loop control increased time in range by about 11 percentage points compared to standard pump therapy — roughly two and a half extra hours per day in the safe zone (Brown et al., 2019).
  • A meta-analysis of home-use trials found closed-loop systems improved glucose control without increasing lows (Beklari et al., 2018).
  • Early home trials showed the biggest gains overnight — when you’re asleep and can’t react (Thabit et al., 2015).

The overnight story is the heart of it. Your glucose can’t wander at 3am because the system is watching.

Who it’s for

Closed loop isn’t for everyone — yet. You need:

  • A compatible pump and CGM.
  • The willingness to wear both.
  • A care team that knows the systems.
  • Realistic expectations: it’s a tool, not a robot butler. You still count carbs, you still bolus for meals, you still deal with sick days.

What it does NOT do

  • It doesn’t eliminate lows (though it reduces them).
  • It doesn’t mean you can ignore your diabetes.
  • It doesn’t work in an instant — it learns your patterns over days.
  • It still needs your input for food.

The honest bottom line

If you’re on a pump and a CGM already, a closed-loop system is the natural next step — and the trials say it adds real, measurable improvement, mostly at night. If you’re on injections, the bridge is usually CGM first, then pump, then loop.

It’s not magic. It’s the best automation we have — and it’s getting better every year.

References

  • Thabit H, et al. Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med. 2015. DOI: 10.1056/NEJMoa1509351
  • Beklari E, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018. DOI: 10.1136/bmj.k1310
  • Brown SA, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019. DOI: 10.1056/NEJMoa1907863